Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is a copy of Press Release tilted 'LASA SUPERGENERICS RESUMES OPERATIONS IN ALL UNITS SITUATED IN MAHAD AND CHIPLUN.' Issued by the company. Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 21, 2021
1)Increase in authorised share capital of the company 2) The Date and time of the Sixth Annual General Meeting for the year ended March 31 2021. 3) The Notice of the Sixth Annual general Meeting (AGM) along with Directors report for the financial year 2020-21. 4) Appointment of Amit R. Dadheech and Associates, Practicing Company Secretaries as a scrutinizer for 6th Annual General Meeting.5) Appointment of Mr. Shivanand hedge the Director who liable to retire by rotation and eligible for re-appointment. 6) Re-appointment of Independent directors of the company for second term of five years. 7)Re-appointment of Dr. Omkar Herlekar for the period of five years. 8) To close Register of Members and Share Transfer Books of the Company from Friday 17th September 2021 to Thursday 23th September 2021 both days inclusive. 9) To convene the Sixth Annual General Meeting of the Company on Friday, the 24th September 2021
Earnings Call for Q1FY22 of Lasa Supergenerics
Conference Call with Lasa Supergenerics Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to our letter dated June 01, 2021 intimating you about the conference call with Analysts/Investors held on June 04, 2021, please find attached the transcript of the aforesaid conference call. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday August 20, 2021 at 11:00 a.m IST to discuss the un-audited financial results of the Company for the quarter ended June 2021. Lasa Supergenerics Ltd - 540702 - Results Financial Results For The Quarter Ended June 30, 2021
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12:00 Noon and concluded at 03: 30 p.m. inter- alia has considered and approved the statement of un-audited financials result along with Limited Review Report for the quarter ended June 30, 2021. Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 14 , 2021
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12:00 Noon and concluded at 03: 30 p.m. inter- alia has considered and approved the statement of un-audited financials result along with Limited Review Report for the quarter ended June 30, 2021. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended June 30 2021 And/Or To Discuss Any Other Business/Matter With The Permission Of The Chair.
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of The Board of Director of the Company is scheduled to be held on Saturday August 14 2021 to consider, approve and take on record un-audited financial results along with Limited review report for the quarter ended June 30 2021 and/or to discuss any other business/matter with the permission of the Chair. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till August 16, 2021. Lasa Supergenerics Ltd - 540702 - Certificate Of Non-Disqualification Of Directors Under Regulation 34(3) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2021.
In pursuant to Regulation 34(3) and Schedule V Para C clause (10) (i) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate of Non Disqualification of Directors for the Financial Year Ended on 31 March, 2021 issued by M/s. Shivam Sharma & Associates., Practicing Company Secretaries, Secretarial Auditors of the Company dated August 04, 2021. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is a copy of Press Release tilted 'No Casualty in any of company's units. Production to recommence in couple of Weeks.' Issued by the company.